Injection in Medical Technology
Navigation Links
Injection in Medical Technology
... Union, SIMPONI given as a 50 mg subcutaneous injection once a month will be indicated for:
... in the US and Canada is a 50 mg subcutaneous injection given once a month.
Important Safety ... AS, 5.8 percent of SIMPONI treated patients had injection site reactions compared with 2.2 percent in ...
... and Canada is 50 mg administered by subcutaneous injection once a month.) At baseline, 66 percent of ... percent, 3 percent and 1 percent of patients, and injection site reactions (ISR) through week 16 occurred in ... in the US and Canada is a 50 mg subcutaneous injection given once a month. Indications in the US: ...
... patients experiencing serious adverse events. injection site reactions occurred in eight percent of ... patients experiencing serious adverse events. injection site reactions occurred in 11 percent of patients ... in the US and Canada is a 50 mg subcutaneous injection given once a month. Indications in the US: ...
... 16.0%), neck pain (4.3% vs 8.5%, vs 10.0%), and injection site pain (2.2% vs 8.5% vs 2.0%) for each group, ... Period, and were treated with NT-201 (up to five injection intervals) over 1 year (48 to 69 weeks). ... rank test) at control visits during all four injection intervals and in all muscle groups. NT 201 was ...
... CV events associated with BYETTA(R) (exenatide) injection use compared to a pooled comparator group treated ... About BYETTA(R) (exenatide) injection BYETTA is the first and only FDA-approved ... for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's ...
... [DAS] for the primary therapeutic target after injection of a 20 U/mL dilution or 50 U/mL dilution was ... from the organization WE MOVE. The individual injection pattern was adapted to patient's needs. A ... total dose was 495 units NT 201. Four weeks after injection 57.1% of patients had an at least 1-point DAS ...
... exenatide once weekly or BYETTA(R) (exenatide) injection for 30 weeks, followed by 74 weeks of treatment ... About BYETTA (R) (exenatide) injection BYETTA is the first and only FDA-approved ... to develop exenatide once weekly, a subcutaneous injection of exenatide for the treatment of type 2 diabetes ...
... in a 1:1 ratio. Each patient received one weekly injection for 3 weeks with 9 follow-up visits over 26 weeks ... infections or skin diseases in the area of the injection site. Common adverse events reported were ... hyoscyamine sulfate), DESMOPRESSIN, DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate). ...
... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... compared with a commercial subcutaneous (SC) injection (2 mg dose), were demonstrated in a Phase I ... adverse effects were comparable to those after SC injection and typical of adverse effects that commonly ... apomorphine is administered by intermittent SC injection usually via a pre-filled autoinjector pen, or ...
... - Single injection in Primates Containing 1,000-Times the Dosage ... preliminary information on the approximate injection frequency that will be needed in human patients. ... this study also support once-weekly or bi-monthly injection frequency in humans. The pilot study ...
... INTRON A (Interferon alfa-2b, recombinant) for injection is contraindicated in patients with ... INTRON A; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were ... (4%) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, ...
... that investigational olanzapine long-acting injection (LAI) therapeutic doses showed a maintenance of ... less than or equal to .05). The incidence of all injection site reactions, including injection pain, was 2.8 percent. Adverse events reported in ...
... adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc., OTCBB: ... delivered with the Biojector(R) 2000 needle-free injection system into either the muscle or the skin. In the ... and some with the Biojector(R) 2000 needle-free injection system into the muscle. The proposed KI/SMI ...
... adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies ... delivered with the Biojector(R) 2000 needle-free injection system into either the muscle or the skin. In the ... and some with the Biojector(R) 2000 needle- free injection system into the muscle. The proposed ...
... on the use of OraVerse (phentolamine mesylate) injection as a local dental anesthetic reversal agent in ... About OraVerse OraVerse (phentolamine mesylate) injection is the only local anesthetic reversal agent that ... deficits resulting from an intraoral submucosal injection of a local anesthetic containing ...
... lives." To reinforce the goals of the injection Impact Report, and to continue to address the ... to patient adherence, the AADE created the injection Impact Report Discussion Group comprised of a ... In response to the results from the injection Impact Report, the Discussion Group is developing ...
... (i.v.) peramivir administered via a single dose injection in the outpatient setting for the treatment of ... Subjects were randomized to receive an i.v. injection of placebo or one of two doses of peramivir (300 ... did not receive adequate dosing by intramuscular injection may not be correct, that HHS and the Food & ...
... observation time point of three minutes after injection -- Significantly faster and greater glucose lowering activity early after injection -- Significantly greater peak insulin levels for ... better overall glycemic control and simplified injection timing." rHuPH20 is the active ingredient in an ...
... 66 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ... 30 subjects) was treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ... 30 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ...
... for once-yearly Reclast(R) (zoledronic acid) injection to include the prevention of new clinical ... the brand name Zometa(R) (zoledronic acid) injection 4 mg administered every three to four weeks in ... . References 1. Reclast(R) (zoledronic acid) injection [Prescribing Information]. East Hanover, NJ: ...
... activity and toxicity were similar between the injection and Injectable Suspension products. -- Of ... patients enrolled, 21 were treated with Kosan's injection product (Cremophor(R)-containing formulation ... 4 of the patients treated initially with the injection formulation crossed over to receive the ...
... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. ... related to tendon or ligament injury (rate per injection = 0.24%). "We believe that this is a great day ... to assess the pharmacokinetics of a single injection of XIAFLEX in 16 subjects with Dupuytren's ...
... more withdrawals due to non-compliance/refusing injection were reported for RLAI (three percent) than ... Long-Acting Injection Risperidone long-acting injection (RLAI) is a long-acting injectable atypical ... FOR RISPERIDONE AND RISPERIDONE LONG-ACTING injection (RLAI) Elderly Patients with dementia-related ...
... issued on January 18th, 2008). "This first injection in patient is a crucial step toward the ... Administering this emulsion through a single injection can offer real medical value to both ... suffering from DME with a single intravitreal injection (inside the eye) of CORTIJECT(R) formulation. The ...
... as follows: -- In rodent intradermal models, injection of bisphosphonates without rHuPH20 created injection site reactions characterized by erythema, ... bioavailability by subcutaneous (SC) injection with rHuPH20 was comparable to IV infusion. ...
... infusion of Reclast(R) (zoledronic acid) injection 5mg was significantly better than risedronate at ... under the brand name Zometa(R) (zoledronic acid) injection 4 mg for use in certain oncology indications(7). ... Inc.; May 2007. 5. Reclast(R) (zoledronic acid) injection [Prescribing Information]. East Hanover, NJ: ...
... (10 to 17 years old). ABILIFY(R) (aripiprazole) injection is indicated for the treatment of adults with ... ready-to-use solution for intramuscular injection 7.5 mg/mL. In adult patients, the ... associated with bipolar mania, the ABILIFY injection initial dose is 9.75 mg/1.3 mL. If ongoing ...
... and Canada is 50 mg administered by subcutaneous injection once a month.) At baseline, 66 percent of ... percent, 3 percent and 1 percent of patients, and injection site reactions (ISR) through week 16 occurred in ... in the US and Canada is a 50 mg subcutaneous injection given once a month. Indications in the US: ...
... patients experiencing serious adverse events. injection site reactions occurred in eight percent of ... patients experiencing serious adverse events. injection site reactions occurred in 11 percent of patients ... in the US and Canada is a 50 mg subcutaneous injection given once a month. Indications in the US: ...
... 16.0%), neck pain (4.3% vs 8.5%, vs 10.0%), and injection site pain (2.2% vs 8.5% vs 2.0%) for each group, ... Period, and were treated with NT-201 (up to five injection intervals) over 1 year (48 to 69 weeks). ... rank test) at control visits during all four injection intervals and in all muscle groups. NT 201 was ...
... CV events associated with BYETTA(R) (exenatide) injection use compared to a pooled comparator group treated ... About BYETTA(R) (exenatide) injection BYETTA is the first and only FDA-approved ... for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's ...
... [DAS] for the primary therapeutic target after injection of a 20 U/mL dilution or 50 U/mL dilution was ... from the organization WE MOVE. The individual injection pattern was adapted to patient's needs. A ... total dose was 495 units NT 201. Four weeks after injection 57.1% of patients had an at least 1-point DAS ...
... exenatide once weekly or BYETTA(R) (exenatide) injection for 30 weeks, followed by 74 weeks of treatment ... About BYETTA (R) (exenatide) injection BYETTA is the first and only FDA-approved ... to develop exenatide once weekly, a subcutaneous injection of exenatide for the treatment of type 2 diabetes ...
... in a 1:1 ratio. Each patient received one weekly injection for 3 weeks with 9 follow-up visits over 26 weeks ... infections or skin diseases in the area of the injection site. Common adverse events reported were ... hyoscyamine sulfate), DESMOPRESSIN, DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate). ...
Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... reactions during degarelix therapy included injection site reactions (e.g. pain, erythema, swelling or ... (mild to moderate). Specifically relating to the injection site adverse reactions, most were transient, of ... few discontinuations (<1%). Grade 3 (severe) injection site reactions occurred in two percent or less of ...... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... either PEGINTRON or PEGINTRON/REBETOL are injection site inflammation/reaction, fatigue/asthenia, ... headache, neutropenia, fatigue, anorexia, injection site erythema and vomiting. In a study with ... There was a 23-24% incidence overall for injection site reactions or inflammation. Individual ...
... compared with a commercial subcutaneous (SC) injection (2 mg dose), were demonstrated in a Phase I ... adverse effects were comparable to those after SC injection and typical of adverse effects that commonly ... apomorphine is administered by intermittent SC injection usually via a pre-filled autoinjector pen, or ...
... - Single injection in Primates Containing 1,000-Times the Dosage ... preliminary information on the approximate injection frequency that will be needed in human patients. ... this study also support once-weekly or bi-monthly injection frequency in humans. The pilot study ...
... INTRON A (Interferon alfa-2b, recombinant) for injection is contraindicated in patients with ... INTRON A; however, the incidence of some (e.g., injection site reactions, fever, rigors, nausea) were ... (4%) and no patient discontinued, and included injection site inflammation and reaction (i.e., bruise, ...
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
... delivered with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc.) (OTC ... delivered with the Biojector(R) 2000 needle-free injection system. Preliminary results indicated that the ... adjuvant and delivered by needle-free injection using the Biojector(R) 2000, were promising. ...Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
... /PRNewswire/ -- A preclinical study involving the injection of adipose-derived stem cells (ADSCs) into the ... of cardiomyocytes (heart cells) subsequent to injection of ADSCs following heart attack, or acute ... cardiomyocyte regeneration and suggest that the injection of ADSCs after AMI may have the potential to help ...China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
... suppositories and Sodium ferulate injection are for the treatment of cardiovascular disease; -- Methionine Vitamin B1 injection is for improving liver function; -- Doxofylline injection is for the treatment of asthma; -- Pantoprazole ...... that investigational olanzapine long-acting injection (LAI) therapeutic doses showed a maintenance of ... less than or equal to .05). The incidence of all injection site reactions, including injection pain, was 2.8 percent. Adverse events reported in ...
... adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies Inc., OTCBB: ... delivered with the Biojector(R) 2000 needle-free injection system into either the muscle or the skin. In the ... and some with the Biojector(R) 2000 needle-free injection system into the muscle. The proposed KI/SMI ...
... adjuvant with the Biojector(R) 2000 needle-free injection system (Bioject Medical Technologies ... delivered with the Biojector(R) 2000 needle-free injection system into either the muscle or the skin. In the ... and some with the Biojector(R) 2000 needle- free injection system into the muscle. The proposed ...
... on the use of OraVerse (phentolamine mesylate) injection as a local dental anesthetic reversal agent in ... About OraVerse OraVerse (phentolamine mesylate) injection is the only local anesthetic reversal agent that ... deficits resulting from an intraoral submucosal injection of a local anesthetic containing ...
... lives." To reinforce the goals of the injection Impact Report, and to continue to address the ... to patient adherence, the AADE created the injection Impact Report Discussion Group comprised of a ... In response to the results from the injection Impact Report, the Discussion Group is developing ...
... (i.v.) peramivir administered via a single dose injection in the outpatient setting for the treatment of ... Subjects were randomized to receive an i.v. injection of placebo or one of two doses of peramivir (300 ... did not receive adequate dosing by intramuscular injection may not be correct, that HHS and the Food & ...
Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
... -- Results of a preclinical study involving the injection of myoblasts modified to express stromal derived ... MyoCell(R) is being delivered via a MyoStar(TM) injection catheter(2), in combination with the NOGA(R) ... Infarction(s) (2) The MYOSTAR(TM) injection Catheter is not available for sale in the U.S. It ...... observation time point of three minutes after injection -- Significantly faster and greater glucose lowering activity early after injection -- Significantly greater peak insulin levels for ... better overall glycemic control and simplified injection timing." rHuPH20 is the active ingredient in an ...
... 66 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ... 30 subjects) was treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ... 30 subjects) will be treated by intramuscular injection of 60 mg of SB-509 (30 mg of SB-509 per leg) into ...
... for once-yearly Reclast(R) (zoledronic acid) injection to include the prevention of new clinical ... the brand name Zometa(R) (zoledronic acid) injection 4 mg administered every three to four weeks in ... . References 1. Reclast(R) (zoledronic acid) injection [Prescribing Information]. East Hanover, NJ: ...
... activity and toxicity were similar between the injection and Injectable Suspension products. -- Of ... patients enrolled, 21 were treated with Kosan's injection product (Cremophor(R)-containing formulation ... 4 of the patients treated initially with the injection formulation crossed over to receive the ...
... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. ... related to tendon or ligament injury (rate per injection = 0.24%). "We believe that this is a great day ... to assess the pharmacokinetics of a single injection of XIAFLEX in 16 subjects with Dupuytren's ...
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
... for NEXIUM(R) I.V. (esomeprazole sodium) for injection to seek approval for use in patients with peptic ... this indication.(2) Presently, NEXIUM I.V. for injection is indicated for the short-term treatment (up to ... sodium) for Injection NEXIUM I.V. for injection is indicated for the short-term treatment (up to ...ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
... a statistically significant reduction in injection site reactions when compared to Navelbine ... and President of ADVENTRX. "The improvement in injection site reactions could translate into a real ... A summary of post-hoc analyses regarding injection site reactions is set forth in the following ...... more withdrawals due to non-compliance/refusing injection were reported for RLAI (three percent) than ... Long-Acting Injection Risperidone long-acting injection (RLAI) is a long-acting injectable atypical ... FOR RISPERIDONE AND RISPERIDONE LONG-ACTING injection (RLAI) Elderly Patients with dementia-related ...
Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
... in this year's Hot Topics program: -- injection Lipolysis (Otherwise known as Mesotherapy or ... will be discussing ASERF's Clinical Trial on injection lipolysis. The trial will study 10 patients receiving four injection lipolysis treatments to one side of their ...... issued on January 18th, 2008). "This first injection in patient is a crucial step toward the ... Administering this emulsion through a single injection can offer real medical value to both ... suffering from DME with a single intravitreal injection (inside the eye) of CORTIJECT(R) formulation. The ...
GlaxoSmithKline Reports Further Progress of Oncology Portfolio
... Safety Information for HYCAMTIN HYCAMTIN for injection is used for the treatment of recurrent ovarian cancer. HYCAMTIN for injection is used for the treatment of small cell ... of your first treatment. HYCAMTIN for injection plus cisplatin is used for the treatment ...... as follows: -- In rodent intradermal models, injection of bisphosphonates without rHuPH20 created injection site reactions characterized by erythema, ... bioavailability by subcutaneous (SC) injection with rHuPH20 was comparable to IV infusion. ...
... infusion of Reclast(R) (zoledronic acid) injection 5mg was significantly better than risedronate at ... under the brand name Zometa(R) (zoledronic acid) injection 4 mg for use in certain oncology indications(7). ... Inc.; May 2007. 5. Reclast(R) (zoledronic acid) injection [Prescribing Information]. East Hanover, NJ: ...
CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
... the NOGA(R) XP mapping system and the MyoStar(TM) injection catheter. These two devices will be used in ... receive training on the NOGA XP system or MyoStar injection catheter, and will work closely with the other ... II heart trial to ensure the safe and accurate injection of FGF-1 into the heart. "We are extremely ...... (10 to 17 years old). ABILIFY(R) (aripiprazole) injection is indicated for the treatment of adults with ... ready-to-use solution for intramuscular injection 7.5 mg/mL. In adult patients, the ... associated with bipolar mania, the ABILIFY injection initial dose is 9.75 mg/1.3 mL. If ongoing ...
Other ContentsstasisstasisorientationorientationorientationorientationorientationorientationsocialsocialsocialsocialsocialsocialsocialsocialdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdiagnosisdysfunctiondysfunctiondysfunctiondysfunctiondysfunctiondysfunctiondysfunctionprosthesisprosthesisprosthesisprosthesismarkersmarkersmarkersmarkersmarkersmarkersmarkersmarkersmarkersOther TagsSTAARFoldable
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ong held secrets of the earth,s history locked in ... very little information on the environments that ... of years. Now, a team of researchers from nine in... tune of $10 million dollars by the National Scien...ngs literally. These scientists will drill throug...
(Date:11/23/2009)...-associated strain of the deadly superbug MRSAan i... antibioticsposes a far greater health threat than...tals, according to a study in the December issue o...eat is easily picked up in fitness centers, school...verall burden of MRSA within hospitals, the report...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Custom Spine Announces New Board of Directors and CFO 52778 1Custom Spine Announces New Board of Directors and CFO 52778 2Olympus Managed Health Care Receives Third Party Administrative License in State of Florida 52776 1Northside Medical Center Nurses Reach Tentative Agreement with Forum Health 52774 1(Date:11/27/2009)...d cycling plus low-emission vehicles may reduce fu... FRIDAY, Nov. 27 (HealthDay News) -- Encouraging c...cars would offer much greater public health benefi....K. researchers have found. , The study compare...ive urban land transport scenarios for London, Eng...
(Date:11/27/2009)... Multi-purpose bilingual coloring b...for use by the business community to educate - inf...jects from Safety issues to Dinosuars to ABC,S and... Saint Louis, MO (PRWEB) November 27, 2009 -- Tod...cs or toys to keep them busy any hour of the day, ...
(Date:11/26/2009)..., PRINCETON, N.J., Nov. 27 The d...t double over the next 25 years and annual medical...billion, up from $113 billion today, according to ...es Care . The National Changing Diabetes ® ...ioned the analysis by a team from the University o...
(Date:11/26/2009)... bigger thrill when on an emotional rollercoaster,...thDay News) -- Call it the fear factor meets the j... spectators -- especially those who root for the w...it,s a closely contested match and victory was in ...r. , Chew on that this Thanksgiving weekend as ...
(Date:11/26/2009)... Benton Communications announces a ...h system for retailers struggling to make an econo...ovember 26, 2009 -- Flu fears is the type of chall...mergency room, according to Dr. David Benton, busi...d business growth system – The Rfactor Inte...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2[0] More Foot Power, Less Car Pollution Best for Health[2] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [1] Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows[0] Watching the Nail-Biting Big Game Hurts So Good[1] Pharmacist Injects Cure for Ailing Businesses
MultipieceSTABIBAGRaysoftBIGBAGTRIPODEHAPTIBAGCollamerBiocrylNaturaLensMemoryLensSTAARFoldableTECNISSoFlex
Other Tagsuptake 2uptake 3productivity 2productivity 3continent 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |